Biotech

A San Francisco startup has begun testing a brain implant in humans that aims to detect and one day treat cancer. Three people have received the device so far.

4. Mai 2026 Von KI berichtet

Nuvation Bio Inc. conducted its first quarter 2026 earnings call on May 4, 2026. The company reviewed financial results for the period ending March 31, 2026, and provided a business update. Executives including CEO David Hung participated in the discussion.

This week saw U.S.-based startups raise significant venture capital, led by $500 million rounds for cryptocurrency firm Ripple and AI parking platform Metropolis. The funding spanned sectors including biotech, cybersecurity, and neurotech. The total for the top 10 rounds exceeded $2 billion, highlighting continued investor interest in innovative technologies.

4. November 2025 Von KI berichtet

Scientists have created a new therapy combining LED technology and nanomaterials to eliminate cancer cells through localized heat, avoiding damage to healthy tissue. This approach aims to provide a safer alternative to traditional chemotherapy and radiotherapy.

Bangkok announced it will host the We Are The World Biotech – AI Innovative & Integrated East-West Medicine Global Summit in November 2025. The event focuses on integrating biotech, AI, and traditional medicine. This nonprofit initiative promotes global health collaboration.

9. September 2025 Von KI berichtet

Biotech company Summit announced promising results from its lung cancer drug in recent trials. The drug demonstrated potential efficacy in treating advanced cases, marking a step forward in oncology treatments. Further studies are planned to confirm these findings.